Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Black Diamond Therapeutics Inc (NASDAQ: BDTX) was $1.72 for the day, up 2.38% from the previous closing price of $1.68. In other words, the price has increased by $2.38 from its previous closing price. On the day, 113.41 million shares were traded. BDTX stock price reached its highest trading level at $2.78 during the session, while it also had its lowest trading level at $1.71.
Ratios:
Our analysis of BDTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.92 and its Current Ratio is at 4.92. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on July 31, 2024, initiated with a Outperform rating and assigned the stock a target price of $20.
Stifel Upgraded its Hold to Buy on June 30, 2023, whereas the target price for the stock was revised from $2 to $10.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 28 ’24 when Versant Venture Capital VI, L. sold 221,600 shares for $6.32 per share. The transaction valued at 1,400,556 led to the insider holds 3,726,341 shares of the business.
David Epstein bought 50,000 shares of BDTX for $310,000 on Jul 31 ’24. On Jul 26 ’24, another insider, David Epstein, who serves as the Former Employee of the company, bought 50,000 shares for $6.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 97458984 and an Enterprise Value of 21070022.
Stock Price History:
The Beta on a monthly basis for BDTX is 2.79, which has changed by -0.68207026 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $7.66, while it has fallen to a 52-week low of $1.59. The 50-Day Moving Average of the stock is -20.38%, while the 200-Day Moving Average is calculated to be -53.92%.
Shares Statistics:
BDTX traded an average of 768.64K shares per day over the past three months and 11759350 shares per day over the past ten days. A total of 56.64M shares are outstanding, with a floating share count of 43.16M. Insiders hold about 23.83% of the company’s shares, while institutions hold 75.06% stake in the company. Shares short for BDTX as of 1740700800 were 7409721 with a Short Ratio of 9.64, compared to 1738281600 on 7054132. Therefore, it implies a Short% of Shares Outstanding of 7409721 and a Short% of Float of 21.990000000000002.
